Report - Lægemidlets navn: Ibrutinib (Bruton`s tyrosine kinase inhibitor ... · N Engl J Med. 2013;369(1):32-42. Fase 1b/2 studie. Anbefaling A. Evidensniveau: 1b Artikel 3: Byrd JC et al.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form